van Oerle R - Search Results

1

Tissue factor pathway inhibitor activity in patients with IDDM.

Leurs PB, van Oerle R, Hamulyak K, Wolffenbuttel BH. Leurs PB, et al. Among authors: van oerle r. Diabetes. 1995 Jan;44(1):80-4. doi: 10.2337/diab.44.1.80. Diabetes. 1995. PMID: 7813818 Clinical Trial.

2

A prothrombinase-based assay for detection of resistance to activated protein C.

Nicolaes GA, Thomassen MC, van Oerle R, Hamulyak K, Hemker HC, Tans G, Rosing J. Nicolaes GA, et al. Among authors: van oerle r. Thromb Haemost. 1996 Sep;76(3):404-10. Thromb Haemost. 1996. PMID: 8883278

3

Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus.

Leurs PB, van Oerle R, Wolffenbuttel BH, Hamulyak K. Leurs PB, et al. Among authors: van oerle r. Thromb Haemost. 1997 Mar;77(3):472-6. Thromb Haemost. 1997. PMID: 9065996

4

The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.

van Oerle R, van Pampus L, Tans G, Rosing J, Hamulyák K. van Oerle R, et al. Among authors: van pampus l. Am J Clin Pathol. 1997 May;107(5):521-6. doi: 10.1093/ajcp/107.5.521. Am J Clin Pathol. 1997. PMID: 9128263

5

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.

Rosing J, Tans G, Nicolaes GA, Thomassen MC, van Oerle R, van der Ploeg PM, Heijnen P, Hamulyak K, Hemker HC. Rosing J, et al. Among authors: van oerle r, van der ploeg pm. Br J Haematol. 1997 Apr;97(1):233-8. doi: 10.1046/j.1365-2141.1997.192707.x. Br J Haematol. 1997. PMID: 9136971 Free article.

6

Acquired APC resistance and oral contraceptives: differences between two functional tests.

Curvers J, Thomassen MC, Nicolaes GA, Van Oerle R, Hamulyak K, Hemker HC, Tans G, Rosing J. Curvers J, et al. Among authors: van oerle r. Br J Haematol. 1999 Apr;105(1):88-94. Br J Haematol. 1999. PMID: 10233368 Free article.

7

Increased D-dimer levels correlate with binding of activated protein C, but not tissue factor expression, on peripheral blood monocytes in cancer patients.

Nijziel MR, van Oerle R, van Pampus EC, de Vet HC, Hillen HF, Hamulyák K. Nijziel MR, et al. Among authors: van pampus ec, van oerle r. Am J Hematol. 2000 Aug;64(4):282-6. doi: 10.1002/1096-8652(200008)64:4<282::aid-ajh8>3.0.co;2-2. Am J Hematol. 2000. PMID: 10911381 Free article.

8

Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon.

Nijziel M, van Oerle R, van 't Veer C, van Pampus E, Lindhout T, Hamulyák K. Nijziel M, et al. Among authors: van pampus e, van t veer c, van oerle r. Br J Haematol. 2001 Jan;112(1):98-104. doi: 10.1046/j.1365-2141.2001.02545.x. Br J Haematol. 2001. PMID: 11167790 Free article.

9

Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.

Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH. Leurs PB, et al. Among authors: van oerle r. Diabetes Care. 2002 Aug;25(8):1340-5. doi: 10.2337/diacare.25.8.1340. Diabetes Care. 2002. PMID: 12145232

10

Acquired resistance to activated protein C in breast cancer patients.

Nijziel MR, van Oerle R, Christella M, Thomassen LG, van Pampus EC, Hamulyák K, Tans G, Rosing J. Nijziel MR, et al. Among authors: van pampus ec, van oerle r. Br J Haematol. 2003 Jan;120(1):117-22. doi: 10.1046/j.1365-2141.2003.03987.x. Br J Haematol. 2003. PMID: 12492586 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters